Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 138
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00777894 | Radiation Therapy in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery | ||
| NCT00004873 | Combination Chemotherapy in Treating Patients With Advanced Stomach Cancer | ||
| NCT00392691 | Melphalan, Yttrium Y 90 Ibritumomab Tiuxetan, and Rituximab Followed by Autologous Stem Cell Transplant in Treating Older Patients With Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous Treatment | ||
| NCT02467582 | Adjuvant Aspirin Treatment for Colon Cancer Patients | ||
| NCT00003757 | Rituximab in Treating Patients With Refractory or Recurrent Hairy Cell Leukemia Following Cladribine Therapy | ||
| NCT00031876 | Capecitabine and Paclitaxel in Treating Patients With Metastatic Breast Cancer | ||
| NCT00020566 | Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma | ||
| NCT01707966 | Orteronel Maintenance Therapy in Patients With Metastatic Castration Resistant Prostate Cancer and Non-progressive Disease After First-line Docetaxel Therapy | ||
| NCT00002526 | Chemotherapy in Treating Patients With Advanced Sarcoma | ||
| NCT00003280 | Monoclonal Antibody Therapy in Treating Patients With Follicular or Mantle Cell Lymphoma | ||
| NCT06090162 | LIBERTY: Liquid Biopsy to Diagnose and Monitor CNS Involvement in High-risk B Cell Non-Hodgkin Lymphoma | ||
| NCT00005060 | Combination Chemotherapy and Surgery in Treating Patients With Locally Advanced Stomach Cancer | ||
| NCT05815927 | Pembrolizumab and Radiotherapy for Oligometastatic Head and Neck Cancer | ||
| NCT06401980 | Darolutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC) | ||
| NCT00003230 | Paclitaxel in Treating Patients With Refractory or Recurrent Acute Leukemia or Chronic Myelogenous Leukemia | ||
| NCT02833766 | Anti-EGFR-immunoliposomes Loaded With Doxorubicin in Patients With Advanced Triple Negative EGFR Positive Breast Cancer | ||
| NCT00568048 | Temozolomide and Bevacizumab in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery | ||
| NCT04630730 | Intravesical Recombinant BCG Followed by Perioperative Chemo-immunotherapy for Patients With MIBC | ||
| NCT00234026 | Gemcitabine in Treating Patients With Newly Diagnosed, Relapsed, or Chemotherapy-Resistant Mantle Cell Lymphoma | ||
| NCT03017326 | Paediatric Hepatic International Tumour Trial | ||
| NCT06452394 | NEODOXy: Targeting Breast Cancer Stem Cells With Doxycycline | ||
| NCT00334594 | Pemetrexed Disodium and Cisplatin Followed by Surgery With or Without Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma | ||
| NCT02964689 | Binimetinib in Addition to Standard Chemotherapy in KRAS Mutated NSCLC. | ||
| NCT04480372 | SAKK 17/18 (ORIGIN) MPM & NSCLC >1st Line Gemci & Atezo Ph II | ||
| NCT01009801 | Transarterial Chemoembolization With Doxorubicin With or Without Everolimus in Treating Patients With Liver Cancer | ||
| NCT02933801 | ODM-201 Maintenance Therapy in Patients With mCRPC Previously Treated With Novel Hormonal Agents. | ||
| NCT01101425 | Male Breast Cancer: Understanding the Biology for Improved Patient Care | ||
| NCT06284122 | Study of Mosunetuzumab Plus Lenalidomide Compared to Anti-CD20 Anti-body + Chemotherapy in Follicular Lymphoma FLIPI2-5 | ||
| NCT00003231 | Combination Chemotherapy Followed by Surgery in Treating Patients With Non-small Cell Lung Cancer | ||
| NCT06358573 | Intratumoral INT230-6 Followed by Neoadjuvant Immuno-chemotherapy in Patients With Early TNBC. INVINCIBLE-4-SAKK | ||
| NCT03762122 | Rogaratinib in Patients With Advanced Pretreated Squamous-cell Non-small Cell Lung Cancer (SQCLC) | ||
| NCT03213301 | Lurbinectedin Monotherapy in Patients With Progressive Malignant Pleural Mesothelioma. | ||
| NCT04604067 | Assessing a ctDNA and PET-oriented Therapy in Patients With DLBCL A Multicenter, Open-label, Phase II Trial. | ||
| NCT00030810 | Combination Chemotherapy Followed by Radiation Therapy Before Surgery in Treating Patients With Stage IIIB NSCLC | ||
| NCT00238381 | Rectal Reconstruction in Treating Patients Who Are Undergoing Surgery for Rectal Cancer | ||
| NCT00031889 | Exemestane With or Without Bicalutamide in Treating Patients With Stage IV Prostate Cancer | ||
| NCT02067741 | CR1447 in Endocrine Responsive-HER2neg and TN-ARpos Breast Cancer | ||
| NCT01593241 | Therapy De-escalation in Seminoma Stage IIA/B | ||
| NCT00003746 | Daily or Weekly Cladribine in Treating Patients With Hairy Cell Leukemia | ||
| NCT00516412 | Everolimus in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma | ||
| NCT02311569 | Sympathicomimetic Agonist in Patients With Myeloproliferative Neoplasms With JAK2-mutation | ||
| NCT04629781 | Open-label Dose Escalation Phase 1b Trial of a New Micellar Docetaxel Compound in Patients With mCRPC | ||
| NCT03620669 | 1st Line Durvalumab in PS 2 NSCLC Patients | ||
| NCT01555281 | Nelfinavir and Lenalidomide/Dexamethasone in Progressive Multiple Myeloma | ||
| NCT03406650 | Neoadjuvant and Adjuvant Durvalumab in Combination With Neoadjuvant Chemotherapy in Patients With Operable Urothelial Cancer. | ||
| NCT00568750 | Dasatinib as First-Line Therapy in Treating Patients With Gastrointestinal Stromal Tumors | ||
| NCT00003214 | Chemosensitivity Testing to Assign Treatment for Patients With Stage III or Stage IV Ovarian Cancer | ||
| NCT02356458 | Combination of Ibrutinib and Bortezomib to Treat Patients With Mantle Cell Lymphoma | ||
| NCT00004935 | Herceptin Followed by Chemotherapy in Treating Women With Metastatic Breast Cancer That Overexpresses HER2 | ||
| NCT00227734 | Capecitabine and Oxaliplatin With or Without Cetuximab in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery |
